# Fund a Medical Cannabis Trial for Children Without NHS Access Since 2018 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/pediatric-medical-cannabis-trials-funding-nhs-access/ > **Published:** 2026-04-21T22:01:53-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:55:30-04:00 > **Clinical Summary:** Support pediatric medical cannabis trials to improve NHS access for children. Funding is crucial to establish safety and efficacy in pediatric cannabis treatments. --- ✦ New CED Clinical Relevance  #86High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Pediatric MedicineEpilepsy[Clinical Trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/)PolicyAccess Why This Matters Six years after the UK legalized medical cannabis, pediatric patients remain largely unable to access treatment through the NHS due to limited clinical evidence and restrictive prescribing guidelines. This petition highlights the urgent need for controlled pediatric trials to establish safety and efficacy data that could inform evidence-based prescribing policies. Clinical Summary The UK legalized medical cannabis in 2018 following high-profile cases of children with severe epilepsy, but NHS access has remained severely limited due to lack of robust clinical trial data in pediatric populations. Current NHS guidelines require exceptional clinical circumstances and specialist approval, creating barriers for families seeking [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). The petition calls for government funding of pediatric medical cannabis trials to generate the evidence needed for broader clinical access. Dr. Caplan’s Take “Without proper pediatric trials, we’re stuck in this impossible position where families know cannabis can help their children, but clinicians can’t prescribe it through standard channels because we lack the safety and dosing data that only well-designed studies can provide. This petition represents a reasonable path forward — fund the research to get the answers we need.” Clinical Perspective 🧠 Clinicians should recognize that current evidence gaps in pediatric [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) create real barriers to care, not just regulatory hurdles. For families considering cannabis treatment, understanding the difference between anecdotal reports and clinical trial data remains crucial for informed decision-making. Any future trials should prioritize safety endpoints and age-appropriate formulations. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Fund%20a%20medical%20cannabis%20trial%20for%20children%20left%20without%20NHS%20access%20since%202018%20-%20...%20%40drcaplan&url=https%3A//petition.parliament.uk/petitions/764594)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//petition.parliament.uk/petitions/764594)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Fund%20a%20medical%20cannabis%20trial%20for%20children%20left%20without%20NHS%20access%20since%202018%20-%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//petition.parliament.uk/petitions/764594)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://petition.parliament.uk/petitions/764594](https://petition.parliament.uk/petitions/764594) Table of Contents - [FAQ](#FAQ)[What is the clinical significance of this cannabis research?](#What_is_the_clinical_significance_of_this_cannabis_research) - [What medical conditions does this study focus on?](#What_medical_conditions_does_this_study_focus_on) - [What type of research methodology was used?](#What_type_of_research_methodology_was_used) - [How does this research impact medical policy?](#How_does_this_research_impact_medical_policy) - [Who would benefit from this research?](#Who_would_benefit_from_this_research) - [Related](#Related) ## FAQ #### What is the clinical significance of this cannabis research? This research has high clinical relevance (#86) with strong evidence that has direct clinical implications. The findings provide important insights for medical practitioners treating patients with cannabis-related therapies. #### What medical conditions does this study focus on? The study primarily focuses on pediatric [epilepsy treatment](https://cedclinic.com/cannabidiol-for-epilepsy-treatment-rare-forms/) using cannabis-based interventions. This represents a specialized area of medicine where cannabis therapies have shown therapeutic potential. #### What type of research methodology was used? This appears to be clinical trial research, which provides controlled, evidence-based data on cannabis treatments. [Clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) are considered the gold standard for evaluating medical interventions and their safety profiles. #### How does this research impact medical policy? The study has policy implications that could influence regulations and guidelines around medical cannabis use. These findings may inform [healthcare policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/) decisions regarding pediatric cannabis treatments. #### Who would benefit from this research? Pediatric patients with epilepsy and their families would be the primary beneficiaries of this research. Healthcare providers specializing in pediatric neurology and [epilepsy treatment](https://cedclinic.com/cannabidiol-for-epilepsy-treatment-rare-forms/) would also benefit from these clinical insights. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoid Clinical Trials: Evidence-Based Pediatric Care](https://cedclinic.com/cannabinoid-use-pediatric-epilepsy-clinical-trials/) Explore clinical trials focused on pediatric cannabis treatments and their role in establishing evidence-based care. [Learn More](https://cedclinic.com/cannabinoid-use-pediatric-epilepsy-clinical-trials/) [Cannabinoids in Pediatric Medicine: Evidence-Based Care and Emerging Research](https://cedclinic.com/cannabinoids-pediatric-clinical-evidence-review/) Discover emerging research on cannabinoids in pediatric medicine and how it informs clinical practice. [Read Article](https://cedclinic.com/cannabinoids-pediatric-clinical-evidence-review/) [Rescheduling marijuana would open the doors for researchers to study THC and CBD.](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) Understand how rescheduling marijuana could facilitate more comprehensive research on THC and CBD, including pediatric studies. [Explore Insights](https://cedclinic.com/rescheduling-marijuana-research-barriers-thc-cbd-studies/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).